MAPT and Alzheimer disease: The t-tau/Aβ42 ratio was significantly higher in prion diseases compared to the other groups, significantly higher in AD compared to FTLD-tau and DLB, and in FTLD-TDP compared to FTLD-tau (Fig. 2e).